jabbrv-ltwa-all.ldf
jabbrv-ltwa-en.ldf
TABLE 1 Patient disease and transplant characteristics by whether a
patient had an RVI |
|
|
|
|
RVI- |
RVI+ |
Overall |
|
(N=127) |
(N=34) |
(N=161) |
Malignant |
|
|
|
Yes |
46 (36.2%) |
15 (44.1%) |
61 (37.9%) |
No |
81 (63.8%) |
19 (55.9%) |
100 (62.1%) |
T Cell Depletion |
|
|
|
Yes |
14 (11.0%) |
4 (11.8%) |
18 (11.2%) |
No |
113 (89.0%) |
30 (88.2%) |
143 (88.8%) |
Myeloblative Conditioning |
|
|
|
Yes |
80 (63.0%) |
28 (82.4%) |
108 (67.1%) |
No |
47 (37.0%) |
6 (17.6%) |
53 (32.9%) |
Serotherapy |
|
|
|
Yes |
56 (44.1%) |
15 (44.1%) |
71 (44.1%) |
No |
71 (55.9%) |
19 (55.9%) |
90 (55.9%) |
Stem Cell Source |
|
|
|
BM |
67 (52.8%) |
26 (76.5%) |
93 (57.8%) |
CORD |
14 (11.0%) |
3 (8.8%) |
17 (10.6%) |
PBSC |
46 (36.2%) |
5 (14.7%) |
51 (31.7%) |
Donor Type |
|
|
|
Match |
75 (59.1%) |
23 (67.6%) |
70 (43.5%) |
Mismatch |
52 (40.9%) |
11 (32.4%) |
91 (56.5%) |
CMV Concordance |
|
|
|
No |
51 (40.2%) |
19 (55.9%) |
70 (43.5%) |
Yes |
76 (59.8%) |
15 (44.1%) |
91 (56.5%) |